Understand the UK public sector market like never before with Tussell Insight.
Book a demoTo provide a comprehensive, end-to-end capillary blood testing service to detect the presence of antibodies generated against SARS-CoV-2 (COVID-19) in the blood. This is the only at-home testing capability not drawing on resource intensive phlebotomy and NHS capacity
To provide a comprehensive, end-to-end capillary blood testing service to detect the presence of antibodies generated against SARS-CoV-2 (COVID-19) in the blood. This is the only at-home testing capability not drawing on resource intensive phlebotomy and NHS capacity
| Contract status | Award notice - awarded |
| Value |
£124M
|
| Contract can renew | No |
| Contract type | Services |
| Contract sector |
|
| Contract locations |
|
| Contract suitable for SME | No |
| Contract suitable for VCO | No |
| Contract notice published | 22 July 2021 |
| Contract tender deadline |
5 July 2021
|
| Contract start | 6 July 2021 |
| Contract end |
5 January 2023 Add contract end date to your calendar |
| Contract duration |
1 year, 6 months
|
| Contact name | Procurement Operations |
| Contact phone | - |
| Contact email | Procurement.operations@dhsc.gov.uk |
| Contract value awarded |
£124M
|
| Contract awarded | 5 July 2021 |
| Supplier Name | City | Region | Country | Sme | Awarded Value |
|---|---|---|---|---|---|
| THRIVA LIMITED | London | United Kingdom | Yes | £124M |